The pen is in your fridge. The prescription is filled. And your brain is doing that thing where it oscillates between excitement and low-grade terror every thirty seconds. Totally normal.
Starting a GLP-1 medication is a significant step — and the first twelve weeks are where most of the adjustment happens. What follows is a practical, honest walkthrough of what you're likely to experience, grounded in clinical data and the lived experiences of thousands of people who've walked this path before you.
Before your first injection
Do these things. You'll thank yourself later.
Stock your kitchen with protein-rich, easy-to-digest foods: eggs, Greek yoghurt, chicken, fish, cottage cheese, bone broth. Also grab ginger tea and some plain crackers — both are genuinely helpful for the nausea that may come. Make sure you have a water bottle you'll actually use, because hydration becomes more important than you think.
Take a "before" photo. Front, side, back. Take measurements — waist, hips, chest. Write down your weight. You will want these in three months, and you'll regret not having them. The scale tells one story. Photos and measurements tell the real one.
Set realistic expectations. You probably won't drop five kilos in week one. The STEP 1 trial showed average weight loss of roughly 15% of body weight — but that was over 68 weeks, not 68 days (Wilding et al., 2021). This is a marathon paced like a marathon.
Weeks 1-2: the quiet start
Your starting dose is intentionally low. This is by design — your body needs time to adjust to the medication before the therapeutic effects fully kick in.
What you might notice: maybe a subtle reduction in appetite, maybe nothing at all. Some people feel a mild wave of nausea the day after their first injection. Others feel completely normal. Both responses are typical.
The most common mistake at this stage is expecting dramatic changes and feeling disappointed when they don't materialise. At the starting dose, you're easing in. Eat normally. Don't restrict aggressively. Pay attention to your body's signals but don't obsess over them.
One user in a popular GLP-1 forum captured it well: "Week one felt like nothing happened. Week three felt like someone had quietly turned down the volume on my appetite without telling me."
Weeks 3-4: the first dose increase
Most protocols step up the dose at week four. This is typically when things start to shift noticeably.
The "food noise" reduction that GLP-1 users talk about often begins here. That constant background hum of thoughts about food — what to eat next, whether to snack, guilt about what you just ate — starts to fade. For people who have lived with that mental chatter for decades, this can be genuinely emotional. It's not uncommon for people to feel a mix of relief and disorientation. You've been fighting your appetite your entire life, and suddenly the fight is... quieter.
Nausea may return temporarily with the dose increase. This is the most commonly reported side effect across all GLP-1 medications, affecting 15-45% of users depending on the drug and dose. The GI tolerability data from the SURMOUNT trials shows that nausea is most frequent during dose escalation periods and typically resolves within days to weeks (Rubino et al., 2025).
This is the stage where protein intake starts mattering. As you naturally eat less, you need every meal to deliver maximum nutritional value. Protein first, always.
Weeks 5-8: settling into the new normal
By now you're on a higher dose and the pattern is establishing itself. Meals feel different — not forced or restrictive, just... smaller. You stop eating because you're satisfied, not because you've used up your willpower allowance for the day.
Weight loss becomes visible. Not just on the scale — your clothes fit differently. Your face may look subtly different. People in your life might start commenting, or they might not yet. The scale typically shows steady, consistent drops rather than dramatic plunges.
Side effects from earlier weeks usually diminish significantly during this phase. Your body has adapted to the medication's effects on gastric emptying. The nausea settles. Energy levels often improve.
This is the stage to establish — or intensify — a resistance training routine. The data on body composition during GLP-1 treatment shows that roughly 25% of weight lost is lean mass, with 75% being fat (Look et al., 2025). Resistance training is the single most effective tool to shift that ratio in favour of preserving muscle.
Weeks 9-12: momentum
You're approaching or at the target therapeutic dose. Results are accumulating. Many people have lost 5-8% of their body weight by this point, with the trajectory pointing toward continued loss.
This is a good time to check in with your doctor. Blood work may show improvements in blood sugar, cholesterol, blood pressure, or liver enzymes — sometimes before you've reached your weight goal. The metabolic benefits often precede the cosmetic ones.
Take those comparison photos now. Compare to your "before" shots. This is usually the moment where the reality of what's happening hits. The scale shows a number, but the photos show a transformation.
The STEP 5 trial demonstrated that weight loss with semaglutide continues well beyond 12 weeks, with sustained results at 2 years for those who remain on treatment (Garvey et al., 2022). You're still early in the journey. The first 12 weeks are the foundation.
The things nobody warns you about
You might need to relearn how to eat. Decades of overeating create habits that don't instantly disappear. Suddenly having a normal appetite can feel confusing. What does a normal portion even look like?
Social situations get complicated. Every dinner, every family gathering, every work lunch revolves around food. You might face questions about why you're eating so little, opinions about your medication choice, or well-meaning relatives who think you're "too thin" when you've barely started.
Your relationship with food changes in ways you didn't expect. Some foods you loved might lose their appeal. Extremely sweet or fatty foods often become less interesting. For most people this feels like a positive shift, but it can catch you off guard.
Constipation is more common than people admit. Slowed gastric emptying affects your whole digestive system. Water, fibre, walking, and possibly a magnesium supplement are your allies here.
This isn't a twelve-week programme. Current evidence shows that weight tends to return when GLP-1 medications are stopped — participants in the STEP 1 extension regained roughly two-thirds of lost weight within a year of stopping (Wilding et al., 2022). Going in with a "quick fix" mindset sets you up for disappointment. This is increasingly understood as a long-term treatment, like medication for high blood pressure.
The bottom line
The first 12 weeks are about adjustment, not perfection. Your body is adapting to new hormonal signals. Your relationship with food is being quietly rewired. Side effects come and go. The scale moves at its own pace.
Your job during this period: eat enough protein, start or continue resistance training, stay hydrated, communicate with your doctor, and give yourself grace. The medication is handling the appetite. Everything else is up to you.
Key Studies & References
We base this guide on peer-reviewed clinical research so you can see exactly where the information comes from.
-
Wilding et al. (2021) — The landmark STEP 1 trial showing approximately 15% body weight reduction with semaglutide 2.4mg over 68 weeks in adults with obesity. The foundational study for Wegovy's approval. Read the full study
-
Garvey et al. (2022) — Two-year follow-up data from STEP 5 confirming that weight loss with semaglutide is sustained over 104 weeks with continued treatment. Read the study on PubMed
-
Rubino et al. (2025) — Comprehensive analysis of gastrointestinal side effects across all four SURMOUNT trials, showing nausea and GI symptoms are most common during dose escalation and typically improve with time. Read the study on PubMed
-
Look et al. (2025) — Body composition substudy of SURMOUNT-1 using DXA scanning, showing approximately 75% of weight lost on tirzepatide is fat mass with 25% lean mass. Read the study on PubMed
-
Wilding et al. (2022) — STEP 1 extension study tracking what happens after stopping semaglutide: participants regained approximately two-thirds of lost weight within one year. Read the study on PubMed
Medical Disclaimer: GLP-1 medications are prescription drugs requiring medical supervision. This guide is for informational purposes only — always consult your healthcare provider before starting or changing any medication.